1. Home
  2. ZNTL vs UEIC Comparison

ZNTL vs UEIC Comparison

Compare ZNTL & UEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • UEIC
  • Stock Information
  • Founded
  • ZNTL 2014
  • UEIC 1986
  • Country
  • ZNTL United States
  • UEIC United States
  • Employees
  • ZNTL N/A
  • UEIC N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • UEIC Consumer Electronics/Appliances
  • Sector
  • ZNTL Health Care
  • UEIC Consumer Staples
  • Exchange
  • ZNTL Nasdaq
  • UEIC Nasdaq
  • Market Cap
  • ZNTL 134.7M
  • UEIC 126.2M
  • IPO Year
  • ZNTL 2020
  • UEIC 1993
  • Fundamental
  • Price
  • ZNTL $2.32
  • UEIC $8.15
  • Analyst Decision
  • ZNTL Buy
  • UEIC Strong Buy
  • Analyst Count
  • ZNTL 8
  • UEIC 2
  • Target Price
  • ZNTL $8.53
  • UEIC $14.50
  • AVG Volume (30 Days)
  • ZNTL 2.7M
  • UEIC 73.5K
  • Earning Date
  • ZNTL 03-04-2025
  • UEIC 02-20-2025
  • Dividend Yield
  • ZNTL N/A
  • UEIC N/A
  • EPS Growth
  • ZNTL N/A
  • UEIC N/A
  • EPS
  • ZNTL N/A
  • UEIC N/A
  • Revenue
  • ZNTL $40,560,000.00
  • UEIC $394,879,000.00
  • Revenue This Year
  • ZNTL N/A
  • UEIC N/A
  • Revenue Next Year
  • ZNTL N/A
  • UEIC $5.38
  • P/E Ratio
  • ZNTL N/A
  • UEIC N/A
  • Revenue Growth
  • ZNTL N/A
  • UEIC N/A
  • 52 Week Low
  • ZNTL $1.61
  • UEIC $7.53
  • 52 Week High
  • ZNTL $18.07
  • UEIC $14.20
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 49.24
  • UEIC 27.48
  • Support Level
  • ZNTL $2.37
  • UEIC $8.89
  • Resistance Level
  • ZNTL $2.36
  • UEIC $10.06
  • Average True Range (ATR)
  • ZNTL 0.25
  • UEIC 0.48
  • MACD
  • ZNTL 0.08
  • UEIC -0.11
  • Stochastic Oscillator
  • ZNTL 69.27
  • UEIC 11.81

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

About UEIC Universal Electronics Inc.

Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.

Share on Social Networks: